Invitae Corporation
NVTA
Classement en actions
#35702
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Prix de l'action
$0.016
Dernière synchronisation: 2024-03-11
Capitalisation boursière
$3.27M
Changement (1 jour)
-5.33%
Changement (1 an)
3,100.00%
Pays
US
Échange Invitae Corporation (NVTA)
Catégorie
Healthcare
Historique du prix de l'action pour Invitae Corporation (NVTA)
Prix de clôture le plus élevé : $0.00 le 2024-05-01
Prix de clôture le plus bas : $0.10 le 2022-02-01
Prix de clôture le plus bas : $0.10 le 2022-02-01
Historique du prix de l'action de Invitae Corporation de 2022 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2024 | -86.45% |
| 2023 | -72.05% |
| 2022 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
